Last update:

Inflammatory disorders news

Immunology

FDA approves Benlysta autoinjector for pediatric patients with active lupus nephritis

The U.S. Food and Drug Administration has approved GSK's autoinjector of Benlysta (belimumab) for subcutaneous injection in patients ≥5 years of age with active lupus nephritis who are receiving standard therapy.

Inflammatory disorders

Aging-related inflammation is not universal across human populations, new study finds

Inflammation, long considered a hallmark of aging, may not be a universal human experience, according to a new study from Columbia University Mailman School of Public Health. The research suggests that "inflammaging"—chronic, ...

Diseases, Conditions, Syndromes

FDA approves Dupixent for bullous pemphigoid

The U.S. Food and Drug Administration has approved Dupixent (dupilumab) for the treatment of adult patients with bullous pemphigoid.

Psychology & Psychiatry

Adult acne increases risk of eating disorders, study indicates

People with acne are at increased risk of developing an eating disorder, a new study says. Adult acne patients are 2.4 times more likely to have an eating disorder, researchers reported recently in the Journal of the European ...

Genetics

FDA approves Zevaskyn for rare, genetic skin disorder

The U.S. Food and Drug Administration has approved Abeona Therapeutics' Zevaskyn (prademagene zamikeracel) for patients with the rare, genetic skin disorder recessive dystrophic epidermolysis bullosa.

Genetics

Scientists discover how circular RNA affects wound healing

Researchers at Karolinska Institutet have identified a new mechanism where circular RNA plays a crucial role in wound healing, which could lead to new therapies to improve wound healing and reduce scarring. The study is published ...